Medical research funding plays a pivotal role in advancing healthcare innovation and ensuring patient safety in research.When funding is at risk or halted, as recently seen with the Trump administration’s freeze on over $2 billion in federal research grants to prestigious institutions like Harvard, the impact can resonate through multiple facets of medical trials.